Markets

Insider Trading

Hedge Funds

Retirement

Opinion

RLX Technology (RLX) Bets Big On Europe And Nicotine Pouches

On August 14, RLX Technology (NYSE:RLX) reported second-quarter results that told two different stories at once. International sales climbed to roughly 70% of revenue as the company absorbed a new European distribution partner, even as trade normalization back home pulled growth down from where the year started. RLX is no longer just an e-vapor device maker. It is trying to become a diversified, direct-to-retail nicotine platform before its home market tightens further.

Europe Becomes The New Battleground

Net revenues reached RMB1.01 billion in the second quarter, up 14.8% year over year, powered by international volume growth and the contribution of a company RLX acquired in May 2025. Gross margin expanded to 35.4% from 27.5% a year earlier, a jump management credited to supply chain optimization and a better mix of products and geographies. Non-GAAP income from operations rose 28.8% to RMB149.6 million, marking the 11th straight quarter of positive non-GAAP operating profit.

In July 2026, RLX took a 51% controlling stake in a Western European distributor that reaches 30,000 retail endpoints and runs a digital ordering platform connecting 20,000 independent merchants, a deal management framed as the next step in building direct retail relationships rather than depending on layers of wholesalers. CEO Kate Wang argued that as vaping hardware becomes commoditized, “competition is shifting from pure product development to route-to-market execution.”

The company is also leaning into modern oral nicotine pouches as a new growth line and is building a manufacturing hub in Southeast Asia to produce them at scale, all while sitting on RMB13.9 billion in total capital resources as of June 30, 2026.

Old Markets Turn More Complicated

The same quarter that produced margin expansion also produced warning signs closer to home. Mainland China revenue is now expected to be roughly flat for the full year, and Sam Tsang, the company’s head of capital markets, said the “procedural time line for government approval has become more conservative” as domestic enforcement tightens. Revenue and margins both moderated sequentially from the first quarter, which had been inflated by a shipment pull-forward tied to regulatory export changes, and management flagged that the elevated 35.4% margin should settle into a lower range going forward.

Selling expenses jumped to RMB123.7 million from RMB84.6 million on higher salary and branding costs tied to the European acquisition, and the company used RMB63.2 million in operating cash during the quarter, a reversal from cash generation in the same period last year. Regulatory friction is not confined to China. The United Kingdom is weighing plain packaging rules, device display bans, restricted flavor names, and limits on dark store operations, and RLX itself is still holding back in the United States, keeping its Premarket Tobacco Product Applications in advanced stages without committing meaningful capital until the regulatory path there looks more durable.

What The Numbers Are Signaling

Hedge fund ownership of RLX slipped from 17 funds to 15 in the most recent quarter, a modest pullback in institutional conviction. Short interest sits at just 1.17% of the float, which points to very little organized bearish positioning against the stock. Fewer funds holding shares alongside almost no short pressure suggests any skepticism here looks more like selective repositioning than a coordinated bet against the company.

Where This Story Goes Next

RLX’s second quarter shows a company mid-transition, trading a China-heavy, wholesale-driven business for a more diversified, direct-to-retail global platform. Europe now carries the growth story, and the new distribution network will only matter if it converts reach into durable margin rather than one-time revenue. Oral nicotine pouches remain an early bet, dependent on the Southeast Asia manufacturing hub reaching real scale.

READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.

Disclosure: None. Follow Insider Monkey on Google News.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.